Market Cap
US$61.4m
Last Updated
2019/09/15 00:17 UTC
Data Sources
Company Financials +
Executive Summary
Pro-Dex, Inc., together with its subsidiaries, designs, develops, and manufactures powered surgical instruments, dental instruments, and rotary air motors worldwide.
Snowflake
Fundamentals
Outstanding track record with excellent balance sheet.
Risks
- Pro-Dex has significant price volatility in the past 3 months.
- Pro-Dex is covered by less than 3 analysts.
Share Price & News
How has Pro-Dex's share price performed over time and what events caused price changes?
Latest Share Price and Events
Market Performance
7 Day Return
10.7%
NasdaqCM:PDEX
-1.2%
US Medical Equipment
1.2%
US Market
1 Year Return
49.3%
NasdaqCM:PDEX
8.7%
US Medical Equipment
1.7%
US Market
PDEX outperformed the Medical Equipment industry which returned 8.7% over the past year.
PDEX outperformed the Market in United States of America which returned 1.7% over the past year.
Share holder returns
| PDEX | Industry | Market | |
|---|---|---|---|
| 7 Day | 10.7% | -1.2% | 1.2% |
| 30 Day | 10.1% | 1.4% | 4.9% |
| 90 Day | 33.3% | 4.8% | 3.7% |
| 1 Year | 49.3%49.3% | 9.6%8.7% | 3.9%1.7% |
| 3 Year | 196.3%196.3% | 70.8%65.5% | 47.2%37.7% |
| 5 Year | 451.3%451.3% | 130.4%104.1% | 60.0%42.4% |
Price Volatility Vs. Market
How volatile is Pro-Dex's share price compared to the market and industry in the last 5 years?
Simply Wall St News
8 months ago | Simply Wall St
Is Pro-Dex, Inc.’s (NASDAQ:PDEX) 19% ROCE Any Good?10 months ago | Simply Wall St
Is Pro-Dex Inc's (NASDAQ:PDEX) 9.4% Better Than Average?1 year ago | Simply Wall St
Pro-Dex Inc (NASDAQ:PDEX): Why Return On Capital Employed Is ImportantValuation
Is Pro-Dex undervalued based on future cash flows and its price relative to the stock market?
15.54x
Price to Earnings (PE) ratio
Intrinsic Value Based on Future Cash Flows
Pro-Dex's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).
Pro-Dex's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).
Price Based on Earnings
Pro-Dex is good value based on earnings compared to the US Medical Equipment industry average.
Pro-Dex is good value based on earnings compared to the United States of America market.
Price Based on Expected Growth
Pro-Dex is poor value based on expected growth next year.
Price Based on Value of Assets
Pro-Dex is good value based on assets compared to the US Medical Equipment industry average.
Next Steps
Future Growth
How is Pro-Dex expected to perform in the next 1 to 3 years based on estimates from 1 analyst?
7.2%
Forecasted annual earnings growth
Earnings and Revenue Growth Estimates
Future Annual Growth Analysis
Pro-Dex's revenue is expected to grow by 3.9% yearly, however this is not considered high growth (20% yearly).
Pro-Dex's earnings are expected to grow by 7.2% yearly, however this is not considered high growth (20% yearly).
Pro-Dex's revenue growth is positive but not above the United States of America market average.
Pro-Dex's earnings growth is positive but not above the United States of America market average.
Pro-Dex's earnings growth is expected to exceed the low risk savings rate of 2.7%.
Earnings per Share Growth Estimates
Future Return on Equity
Unable to establish if Pro-Dex will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
Next Steps
Past Performance
How has Pro-Dex performed over the past 5 years?
46.6%
Historical annual earnings growth
Earnings and Revenue History
Past Earnings Growth Analysis
Pro-Dex has delivered over 20% year on year earnings growth in the past 5 years.
Pro-Dex's 1-year earnings growth exceeds its 5-year average (155.9% vs 46.6%)
Pro-Dex's earnings growth has exceeded the US Medical Equipment industry average in the past year (155.9% vs 28.9%).
Return on Equity
Pro-Dex has efficiently used shareholders’ funds last year (Return on Equity greater than 20%).
Return on Assets
Pro-Dex used its assets more efficiently than the US Medical Equipment industry average last year based on Return on Assets.
Return on Capital Employed
Pro-Dex has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).
Next Steps
Financial Health
How is Pro-Dex's financial position?
Financial Position Analysis
Pro-Dex is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Pro-Dex's cash and other short term assets cover its long term commitments.
Debt to Equity History and Analysis
Pro-Dex's level of debt (26.5%) compared to net worth is satisfactory (less than 40%).
The level of debt compared to net worth has increased over the past 5 years (0% vs 26.5% today).
Debt is well covered by operating cash flow (73.8%, greater than 20% of total debt).
Pro-Dex earns more interest than it pays, coverage of interest payments is not a concern.
Balance Sheet
High level of physical assets or inventory.
Debt is covered by short term assets, assets are 4.8x debt.
Next Steps
Dividend
What is Pro-Dex's current dividend yield, its reliability and sustainability?
Dividend Yield and Payments Analysis
Unable to evaluate Pro-Dex's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
Unable to evaluate Pro-Dex's dividend against the top 25% market benchmark as the company has not reported any payouts.
Unable to perform a dividend volatility check as Pro-Dex has not reported any payouts.
Unable to verify if Pro-Dex's dividend has been increasing as the company has not reported any payouts.
Current Payout to Shareholders
Unable to calculate sustainability of dividends as Pro-Dex has not reported any payouts.
Future Payout to Shareholders
Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
Next Steps
Management
What is the CEO of Pro-Dex's salary, the management and board of directors tenure and is there insider trading?
6.7yrs
Average board tenure
CEO
Rick Van Kirk (58yo)
4.7yrs
Tenure
US$287,156
Compensation
Mr. Richard Lee Van Kirk, Jr., also known as Rick, has been the Chief Executive Officer and President of Pro-Dex Inc., since January 12, 2015 and has been its Chief Operating Officer since April 23, 2013. ...
CEO Compensation Analysis
Rick's remuneration is lower than average for companies of similar size in United States of America.
Rick's compensation has been consistent with company performance over the past year, both up more than 20%.
Board Age and Tenure
6.7yrs
Average Tenure
56yo
Average Age
The tenure for the Pro-Dex board of directors is about average.
Insider Trading
No 3 month open market individual insider trading information.
Recent Insider Transactions
| Entity | Individual |
| Role | Chief Executive Officer CEO, President |
| Shares | 3,500 |
| Max Price | US$13.25 |
| Entity | Individual |
| Role | Member of the Board of Directors Director |
| Shares | 2,700 |
| Max Price | US$14.34 |
| Entity | Company |
| Shares | 25,561 |
| Max Price | US$15.74 |
| Entity | Individual |
| Role | Chief Financial Officer CFO & Corporate Secretary |
| Shares | 2,114 |
| Max Price | US$15.81 |
| Entity | Individual |
| Role | Member of the Board of Directors Director |
| Shares | 7,000 |
| Max Price | US$13.15 |
| Entity | Company |
| Shares | 5,160 |
| Max Price | US$14.65 |
| Entity | Company |
| Shares | 24,827 |
| Max Price | US$14.73 |
| Entity | Individual |
| Role | Chief Executive Officer CEO, President |
| Shares | 1,500 |
| Max Price | US$14.30 |
| Entity | Company |
| Shares | 12,091 |
| Max Price | US$14.74 |
| Entity | Company |
| Shares | 8,043 |
| Max Price | US$14.43 |
| Entity | Company |
| Shares | 9,691 |
| Max Price | US$14.80 |
| Entity | Company |
| Shares | 39,130 |
| Max Price | US$14.25 |
| Entity | Company |
| Shares | 26,116 |
| Max Price | US$14.25 |
| Entity | Company |
| Shares | 6,000 |
| Max Price | US$15.21 |
Ownership Breakdown
Management Team
Alisha Charlton (49yo)
CFO & Corporate Secretary
- Tenure: 4.7yrs
- Compensation: US$193.92k
Rick Van Kirk (58yo)
CEO, President
- Tenure: 4.7yrs
- Compensation: US$287.16k
Board Members
Ray Cabillot (56yo)
Director
- Tenure: 6.7yrs
- Compensation: US$18.00k
David Hovda (56yo)
Director
- Tenure: 6.7yrs
- Compensation: US$25.00k
Nick Swenson (50yo)
Chairman of the Board
- Tenure: 0yrs
- Compensation: US$18.00k
Rick Van Kirk (58yo)
CEO, President
- Tenure: 4.7yrs
- Compensation: US$287.16k
Bill Farrell (46yo)
Director
- Tenure: 6.7yrs
- Compensation: US$18.00k
Company Information
Pro-Dex, Inc.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: Pro-Dex, Inc.
- Ticker: PDEX
- Exchange: NasdaqCM
- Founded: 1978
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: US$61.362m
- Shares outstanding: 3.99m
- Website: https://www.pro-dex.com
Number of Employees
Location
- Pro-Dex, Inc.
- 2361 McGaw Avenue
- Irvine
- California
- 92614
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| PDEX | NasdaqCM (Nasdaq Capital Market) | Yes | Common Stock | US | USD | Aug 1986 |
| PDXN | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Aug 1986 |
Biography
Pro-Dex, Inc., together with its subsidiaries, designs, develops, and manufactures powered surgical instruments, dental instruments, and rotary air motors worldwide. It also manufactures plastic injection ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2019/09/15 00:17 |
| End of Day Share Price | 2019/09/13 00:00 |
| Earnings | 2019/06/30 |
| Annual Earnings | 2019/06/30 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.